During circulation, cancer cells, now termed circulating tumor cells (CTCs), face numerous challenges, including immune surveillance, shear stress, and the need to survive in a non-adhesive environment. To overcome these obstacles, CTCs can travel as clusters or form interactions with platelets to shield themselves from immune detection. Additionally, they may undergo adaptations that increase their resistance to apoptosis, thereby enhancing their survival during transit.
